These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 21680301)
1. The EORTC information questionnaire, EORTC QLQ-INFO25. Validation study for Spanish patients. Arraras JI; Manterola A; Hernández B; Arias de la Vega F; Martínez M; Vila M; Eito C; Vera R; Domínguez MÁ Clin Transl Oncol; 2011 Jun; 13(6):401-10. PubMed ID: 21680301 [TBL] [Abstract][Full Text] [Related]
2. An international field study for the reliability and validity of the EORTC communication questionnaire EORTC QLQ-COMU26. Arraras JI; Giesinger J; Shamieh O; Bahar I; Koller M; Bredart A; Costantini A; Greimel E; Sztankay M; Wintner LM; de Sousa MC; Ishiki H; Kontogianni M; Wolan M; Kikawa Y; Lanceley A; Gioulbasanis I; Harle A; Zarandona U; Kulis D; Kuljanic K; Health Qual Life Outcomes; 2024 Oct; 22(1):87. PubMed ID: 39385305 [TBL] [Abstract][Full Text] [Related]
3. The EORTC cancer in-patient satisfaction with care questionnaire: EORTC IN-PATSAT32 Validation study for Spanish patients. Arraras JI; Vera R; Martínez M; Hernández B; Laínez N; Rico M; Vila M; Chicata V; Asín G Clin Transl Oncol; 2009 Apr; 11(4):237-42. PubMed ID: 19380301 [TBL] [Abstract][Full Text] [Related]
4. Validation study of the EORTC information questionnaire (EORTC QLQ-INFO25) in Iranian cancer patients. Asadi-Lari M; Ahmadi Pishkuhi M; Almasi-Hashiani A; Safiri S; Sepidarkish M Support Care Cancer; 2015 Jul; 23(7):1875-82. PubMed ID: 25475735 [TBL] [Abstract][Full Text] [Related]
5. Validation of EORTC IN-PATSAT32 for Chinese cancer patients. Zhang L; Dai Z; Cheng S; Xie S; Woo SM; Luo Z; Wu J; Gao T; Liu J; Zhang K; Zhang J; Jia X; Miller AR; Wang C Support Care Cancer; 2015 Sep; 23(9):2721-30. PubMed ID: 25663542 [TBL] [Abstract][Full Text] [Related]
6. The EORTC Quality of Life Questionnaire for patients with prostate cancer: EORTC QLQ-PR25. Validation study for Spanish patients. Arraras JI; Villafranca E; Arias de la Vega F; Romero P; Rico M; Vila M; Asín G; Chicata V; Domínguez MA; Lainez N; Manterola A; Martínez E; Martínez M Clin Transl Oncol; 2009 Mar; 11(3):160-4. PubMed ID: 19293053 [TBL] [Abstract][Full Text] [Related]
7. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15. Hjermstad MJ; Bergenmar M; Bjordal K; Fisher SE; Hofmeister D; Montel S; Nicolatou-Galitis O; Pinto M; Raber-Durlacher J; Singer S; Tomaszewska IM; Tomaszewski KA; Verdonck-de Leeuw I; Yarom N; Winstanley JB; Herlofson BB; Support Care Cancer; 2016 Sep; 24(9):3915-24. PubMed ID: 27113466 [TBL] [Abstract][Full Text] [Related]
8. Psychometric validation of the European Organisation for Research and Treatment of Cancer-Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22). Greimel E; Nagele E; Lanceley A; Oberguggenberger AS; Nordin A; Kuljanic K; Arraras JI; Wei-Chu C; Jensen PT; Tomaszewski KA; Creutzberg CL; Galalae R; Toelen H; Zimmermann K; Bjelic-Radisic V; Costantini A; Almont T; Serpentini S; Paskeviciute Frøding L; Vistad I; Schmalz C; Eur J Cancer; 2021 Sep; 154():235-245. PubMed ID: 34298374 [TBL] [Abstract][Full Text] [Related]
9. Psychometric properties of the Persian version of satisfaction with care EORTC-in-patsat32 questionnaire among Iranian cancer patients. Pishkuhi MA; Salmaniyan S; Nedjat S; Zendedel K; Lari MA Asian Pac J Cancer Prev; 2014; 15(23):10121-8. PubMed ID: 25556436 [TBL] [Abstract][Full Text] [Related]
10. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26. Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B; BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889 [TBL] [Abstract][Full Text] [Related]
11. The EORTC cancer outpatient satisfaction with care questionnaire in ambulatory radiotherapy: EORTC OUT-PATSAT35 RT. Validation study for Spanish patients. Arraras JI; Rico M; Vila M; Chicata V; Asin G; Martinez M; Hernandez B; Arias F; Martinez E Psychooncology; 2010 Jun; 19(6):657-64. PubMed ID: 19771588 [TBL] [Abstract][Full Text] [Related]
12. The EORTC Quality of Life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients. Arraras JI; Suárez J; Arias de la Vega F; Vera R; Asín G; Arrazubi V; Rico M; Teijeira L; Azparren J Clin Transl Oncol; 2011 Jan; 13(1):50-6. PubMed ID: 21239355 [TBL] [Abstract][Full Text] [Related]
13. Cultural adaptation and validation of the Korean version of the EORTC QLQ-CR29 in patients with colorectal cancer. Ihn MH; Lee SM; Son IT; Park JT; Oh HK; Kim DW; Kang SB Support Care Cancer; 2015 Dec; 23(12):3493-501. PubMed ID: 25824366 [TBL] [Abstract][Full Text] [Related]
14. The EORTC QLQ-ELD14 questionnaire for elderly cancer patients. Validation study for elderly Spanish breast cancer patients. Arraras JI; Asin G; Illarramendi JJ; Manterola A; Salgado E; Dominguez MA Rev Esp Geriatr Gerontol; 2019; 54(6):321-328. PubMed ID: 31266659 [TBL] [Abstract][Full Text] [Related]
15. An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32). Brédart A; Bottomley A; Blazeby JM; Conroy T; Coens C; D'Haese S; Chie WC; Hammerlid E; Arraras JI; Efficace F; Rodary C; Schraub S; Costantini M; Costantini A; Joly F; Sezer O; Razavi D; Mehlitz M; Bielska-Lasota M; Aaronson NK; Eur J Cancer; 2005 Sep; 41(14):2120-31. PubMed ID: 16182120 [TBL] [Abstract][Full Text] [Related]
16. Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer. Ripping TM; Rammant E; Witjes JA; Aaronson NK; van Hemelrijck M; van Hoogstraten LMC; ; Kiemeney LA; Aben KKH Health Qual Life Outcomes; 2022 Dec; 20(1):171. PubMed ID: 36581934 [TBL] [Abstract][Full Text] [Related]
17. An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients. Arraras JI; Greimel E; Sezer O; Chie WC; Bergenmar M; Costantini A; Young T; Vlasic KK; Velikova G Eur J Cancer; 2010 Oct; 46(15):2726-38. PubMed ID: 20674333 [TBL] [Abstract][Full Text] [Related]
18. The eortc quality of life questionnaire QLQ-C30 (version 3.0). Validation study for Spanish prostate cancer patients. Arraras Urdaniz JI; Villafranca Iturre E; Arias de la Vega F; Domínguez Domínguez MA; Lainez Milagro N; Manterola Burgaleta A; Martínez Lopez E; Romero Rojano P; Martínez Aguillo M Arch Esp Urol; 2008 Oct; 61(8):949-54. PubMed ID: 19040169 [TBL] [Abstract][Full Text] [Related]
19. Further evaluation of the EORTC QLQ-C30 psychometric properties in a large Brazilian cancer patient cohort as a function of their educational status. Paiva CE; Carneseca EC; Barroso EM; de Camargos MG; Alfano AC; Rugno FC; Paiva BS Support Care Cancer; 2014 Aug; 22(8):2151-60. PubMed ID: 24652051 [TBL] [Abstract][Full Text] [Related]
20. The EORTC QLQ-C15-PAL questionnaire: validation study for Spanish bone metastases patients. Arraras JI; de la Vega FA; Asin G; Rico M; Zarandona U; Eito C; Cambra K; Barrondo M; Errasti M; Verdún J; Rivadeneira J; Dominguez MA Qual Life Res; 2014 Apr; 23(3):849-55. PubMed ID: 24002479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]